File Download
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Article: Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine
  • Basic View
  • Metadata View
  • XML View
TitlePhase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine
 
AuthorsSandhya, V
Schlesinger, SJ5 10
Chen, Z5 10 2
Hurley, A5 10
Lombardo, A11
Than, S13 11
Adesanya, P11 7
Bunce, C8
Boaz, M1 11
Boyle, R11
Sayeed, E11
Clark, L9
Dugin, D5
Boente-Carrera, M5
Schmidt, C11
Fang, Q5
LeiBa,5 3
Huang, Y5 10
Zaharatos, GJ5 10 14
Gardiner, DF5 12 6
Caskey, M10
Seamons, L4
Ho, M4
Dally, L4
Smith, C4
Cox, J9
Gill, D9
Gilmour, J9
Keefer, MC8
Fast, P11
Ho, DD5 10
 
Issue Date2010
 
PublisherPublic Library of Science. The Journal's web site is located at http://www.plosone.org/home.action
 
CitationP L O S ONE, 2010, v. 5 n. 1, article no. e8816 [How to Cite?]
DOI: http://dx.doi.org/10.1371/journal.pone.0008816
 
ISSN1932-6203
2013 Impact Factor: 3.534
2013 SCImago Journal Rankings: 1.724
 
DOIhttp://dx.doi.org/10.1371/journal.pone.0008816
 
PubMed Central IDPMC2810329
 
ISI Accession Number IDWOS:000273896300005
Funding AgencyGrant Number
International AIDS Vaccine Initiative (IAVI)
United States for International Development (USAID)
Rockefeller University
University of Rochester Clinical and Translational Science
Funding Information:

Funding for this study was provided by the International AIDS Vaccine Initiative (IAVI) and its donors, including the generous support of the American people through the United States for International Development (USAID). IAVI played a direct role in study design, data collection and analysis, decision to publish, and preparation of this manuscript. Support was also provided by the Rockefeller University and University of Rochester Clinical and Translational Science Awards.

 
DC FieldValue
dc.contributor.authorSandhya, V
 
dc.contributor.authorSchlesinger, SJ
 
dc.contributor.authorChen, Z
 
dc.contributor.authorHurley, A
 
dc.contributor.authorLombardo, A
 
dc.contributor.authorThan, S
 
dc.contributor.authorAdesanya, P
 
dc.contributor.authorBunce, C
 
dc.contributor.authorBoaz, M
 
dc.contributor.authorBoyle, R
 
dc.contributor.authorSayeed, E
 
dc.contributor.authorClark, L
 
dc.contributor.authorDugin, D
 
dc.contributor.authorBoente-Carrera, M
 
dc.contributor.authorSchmidt, C
 
dc.contributor.authorFang, Q
 
dc.contributor.authorLeiBa,
 
dc.contributor.authorHuang, Y
 
dc.contributor.authorZaharatos, GJ
 
dc.contributor.authorGardiner, DF
 
dc.contributor.authorCaskey, M
 
dc.contributor.authorSeamons, L
 
dc.contributor.authorHo, M
 
dc.contributor.authorDally, L
 
dc.contributor.authorSmith, C
 
dc.contributor.authorCox, J
 
dc.contributor.authorGill, D
 
dc.contributor.authorGilmour, J
 
dc.contributor.authorKeefer, MC
 
dc.contributor.authorFast, P
 
dc.contributor.authorHo, DD
 
dc.date.accessioned2010-10-31T11:37:45Z
 
dc.date.available2010-10-31T11:37:45Z
 
dc.date.issued2010
 
dc.description.naturepublished_or_final_version
 
dc.identifier.citationP L O S ONE, 2010, v. 5 n. 1, article no. e8816 [How to Cite?]
DOI: http://dx.doi.org/10.1371/journal.pone.0008816
 
dc.identifier.doihttp://dx.doi.org/10.1371/journal.pone.0008816
 
dc.identifier.hkuros181668
 
dc.identifier.isiWOS:000273896300005
Funding AgencyGrant Number
International AIDS Vaccine Initiative (IAVI)
United States for International Development (USAID)
Rockefeller University
University of Rochester Clinical and Translational Science
Funding Information:

Funding for this study was provided by the International AIDS Vaccine Initiative (IAVI) and its donors, including the generous support of the American people through the United States for International Development (USAID). IAVI played a direct role in study design, data collection and analysis, decision to publish, and preparation of this manuscript. Support was also provided by the Rockefeller University and University of Rochester Clinical and Translational Science Awards.

 
dc.identifier.issn1932-6203
2013 Impact Factor: 3.534
2013 SCImago Journal Rankings: 1.724
 
dc.identifier.issue1, article no. e8816
 
dc.identifier.openurl
 
dc.identifier.pmcidPMC2810329
 
dc.identifier.pmid20111599
 
dc.identifier.scopuseid_2-s2.0-77749321171
 
dc.identifier.urihttp://hdl.handle.net/10722/125550
 
dc.identifier.volume5
 
dc.languageeng
 
dc.publisherPublic Library of Science. The Journal's web site is located at http://www.plosone.org/home.action
 
dc.relation.ispartofP L O S ONE
 
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License
 
dc.subject.meshAIDS Vaccines - administration and dosage - adverse effects - immunology
 
dc.subject.meshDose-Response Relationship, Immunologic
 
dc.subject.meshDouble-Blind Method
 
dc.subject.meshHIV-1 - immunology
 
dc.subject.meshVaccinia virus - genetics
 
dc.titlePhase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine
 
dc.typeArticle
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Sandhya, V</contributor.author>
<contributor.author>Schlesinger, SJ</contributor.author>
<contributor.author>Chen, Z</contributor.author>
<contributor.author>Hurley, A</contributor.author>
<contributor.author>Lombardo, A</contributor.author>
<contributor.author>Than, S</contributor.author>
<contributor.author>Adesanya, P</contributor.author>
<contributor.author>Bunce, C</contributor.author>
<contributor.author>Boaz, M</contributor.author>
<contributor.author>Boyle, R</contributor.author>
<contributor.author>Sayeed, E</contributor.author>
<contributor.author>Clark, L</contributor.author>
<contributor.author>Dugin, D</contributor.author>
<contributor.author>Boente-Carrera, M</contributor.author>
<contributor.author>Schmidt, C</contributor.author>
<contributor.author>Fang, Q</contributor.author>
<contributor.author>LeiBa,</contributor.author>
<contributor.author>Huang, Y</contributor.author>
<contributor.author>Zaharatos, GJ</contributor.author>
<contributor.author>Gardiner, DF</contributor.author>
<contributor.author>Caskey, M</contributor.author>
<contributor.author>Seamons, L</contributor.author>
<contributor.author>Ho, M</contributor.author>
<contributor.author>Dally, L</contributor.author>
<contributor.author>Smith, C</contributor.author>
<contributor.author>Cox, J</contributor.author>
<contributor.author>Gill, D</contributor.author>
<contributor.author>Gilmour, J</contributor.author>
<contributor.author>Keefer, MC</contributor.author>
<contributor.author>Fast, P</contributor.author>
<contributor.author>Ho, DD</contributor.author>
<date.accessioned>2010-10-31T11:37:45Z</date.accessioned>
<date.available>2010-10-31T11:37:45Z</date.available>
<date.issued>2010</date.issued>
<identifier.citation>P L O S ONE, 2010, v. 5 n. 1, article no. e8816</identifier.citation>
<identifier.issn>1932-6203</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/125550</identifier.uri>
<language>eng</language>
<publisher>Public Library of Science. The Journal&apos;s web site is located at http://www.plosone.org/home.action</publisher>
<relation.ispartof>P L O S ONE</relation.ispartof>
<rights>Creative Commons: Attribution 3.0 Hong Kong License</rights>
<subject.mesh>AIDS Vaccines - administration and dosage - adverse effects - immunology</subject.mesh>
<subject.mesh>Dose-Response Relationship, Immunologic</subject.mesh>
<subject.mesh>Double-Blind Method</subject.mesh>
<subject.mesh>HIV-1 - immunology</subject.mesh>
<subject.mesh>Vaccinia virus - genetics</subject.mesh>
<title>Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B&apos;/C candidate vaccine</title>
<type>Article</type>
<identifier.openurl>http://library.hku.hk:4550/resserv?sid=HKU:IR&amp;issn=1932-6203&amp;volume=5&amp;issue=1, article no. e8816&amp;spage=&amp;epage=&amp;date=2010&amp;atitle=Phase+1+safety+and+immunogenicity+evaluation+of+ADMVA,+a+multigenic,+modified+vaccinia+Ankara-HIV-1+B%27/C+candidate+vaccine</identifier.openurl>
<description.nature>published_or_final_version</description.nature>
<identifier.doi>10.1371/journal.pone.0008816</identifier.doi>
<identifier.pmid>20111599</identifier.pmid>
<identifier.pmcid>PMC2810329</identifier.pmcid>
<identifier.scopus>eid_2-s2.0-77749321171</identifier.scopus>
<identifier.hkuros>181668</identifier.hkuros>
<identifier.volume>5</identifier.volume>
<identifier.issue>1, article no. e8816</identifier.issue>
<identifier.isi>WOS:000273896300005</identifier.isi>
<bitstream.url>http://hub.hku.hk/bitstream/10722/125550/1/pone.0008816.pdf</bitstream.url>
</item>
Author Affiliations
  1. Sanofi Pasteur
  2. The University of Hong Kong Li Ka Shing Faculty of Medicine
  3. Schering-Plough Biopharma
  4. The EMMES Corporation
  5. Aaron Diamond AIDS Research Center
  6. Bristol-Myers Squibb
  7. Novartis Pharma
  8. University of Rochester Medical Center
  9. Imperial College London
  10. Rockefeller University
  11. International AIDS Vaccine Initiative
  12. Weill Cornell Medical Center
  13. Pfizer
  14. McGill University